Posted On: 03/25/2016 2:54:26 PM
Post# of 72441
CTIX will be presenting at ASM Microbe 2016 on June 19-20.
Pharmacokinetic-pharmacodynamic(Pk?Pd) Analyses for Efficacy and Safety of Brilacidin (Bri) Using Data fromPatients with Acute Bacterial Skin and Skin Structure Infections (Absssi)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18058
Application of Pharmacokinetic-Pharmacodynamic (Pk‑Pd) Models for Brilacidin (Bri) Dose Selection Support for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18096
Pharmacokinetic-pharmacodynamic(Pk?Pd) Analyses for Efficacy and Safety of Brilacidin (Bri) Using Data fromPatients with Acute Bacterial Skin and Skin Structure Infections (Absssi)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18058
Application of Pharmacokinetic-Pharmacodynamic (Pk‑Pd) Models for Brilacidin (Bri) Dose Selection Support for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
http://www.abstractsonline.com/pp8/#!/4060/pr...tion/18096
(0)
(0)
Scroll down for more posts ▼
